Free press releases distribution network?

Agency / Source: The Deciding Factor, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



New Healthcare Investment Firm Focuses on Unmet Medical Needs - AshHill Pharmaceutical Investments, LLC, a private equity fund focused on investing in pharmaceutical and medical device companies has opened their doors and is currently investing in several innovative healthcare organizations - AshHill.net
New Healthcare Investment Firm Focuses on Unmet Medical Needs

 

PRZOOM - /newswire/ - Mason, OH, United States, 2012/05/02 - AshHill Pharmaceutical Investments, LLC, a private equity fund focused on investing in pharmaceutical and medical device companies has opened their doors and is currently investing in several innovative healthcare organizations - AshHill.net.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

AshHill Pharmaceutical Investments, LLC, a private equity fund focused on investing in innovative pharmaceutical and medical device companies, has opened their doors and is already in the process of investing in several cutting edge healthcare organizations.

The AshHill executive team includes leaders in medicine and business, among them Dr. Peter Milner, a board certified physician and cardiologist; David Buffenbarger, a certified public accountant; Steven Smith, an attorney that specializes in business law; and Eric Ott, an experienced investment management professional.

The stated goal of AshHill is to help both established and seed-stage companies overcome industry challenges and surpass business goals by providing necessary equity capital. These efforts allow innovative medical and pharmaceutical companies to expand, hire new employees and reach their potential to improve patient care. The firm’s primary focus is on companies that are working on areas of unmet medical need.

“We recognize the future of healthcare is focused on reducing cost, yet improving overall care. We look to invest in companies that have worked hard to find solutions that align with both, from a pharmaceutical company developing antibiotics to combat super-bugs to a medical device company offering a non-surgical alternative to a chronic illness affecting millions of people,” said Milner, president and CEO of AshHill. “Unlike other traditional venture capital groups, our organization is an advocate for public health, and we are committed to helping viable, yet early-stage companies that are working to find imperative healthcare solutions.”

Milner has co-founded several successful pharmaceutical and biomedical startups throughout the years including Optivia Biotechnology, a private company now recognized as a leader in the emerging field of transporter biology, ARYx Therapeutics (NASDAQ: ARYX) and CV Therapeutics (NASDAQ: CVTX), which was later acquired by Gilead for $1.5 billion in 2009.

The firm has a global reach, working with companies that span the globe from California to London, and has offices in Fort Thomas, Ky., in metropolitan Cincinnati, and Silicon Valley.

“As an organization, our biggest asset is having a team that has the know-how and experience necessary to be successful,” Smith said. “Peter has more than 25 years of medical experience and numerous patents, as well as strong connections to the industry as a whole. His expertise combined with other medical specialists and the rest of our team’s financial and business acumen gives us an incredible advantage.”

While the firm is open to investing in companies across all spectrums of development and approval stages, they are committed to finding companies that are generating products that have a significant impact. Recent investments include:

• SinuSys, located in Palo Alto, Calif., the developer of a medical device that offers a minimally invasive, office-based alternative to surgery to treat sinusitis, a condition affecting more than 37 million Americans.
• Heart Metabolics, located in London, U.K., a pharmaceutical company that developed a medication for the treatment of hypertrophic cardiomyopathy (HCM), a genetic condition that leads to the thickening of the heart wall. It is best known as a cause of sudden cardiac death in young athletes, affects about 10,000 Americans and has few treatment options currently available.
• Armetheon, a pharmaceutical company working on antibiotics to combat an epidemic of drug-resistant bacteria, or superbugs, that are frequent causes of serious infections, especially in the hospital environment.

“Our objective is to invest in companies that are working to meet these kinds of unmet medical needs,” Buffenbarger said. “We are a unique investment firm because each of us brings a specific industry skill set to the organization. We have a perspective that allows us to identify products with a great potential for profit, as well as great potential to improve public health.”

“SinuSys is a perfect example of the types of investments we are looking for as their device will help more than 21 million people who suffer from chronic sinusitis,” Buffenbarger said. “The need is great, so the decision to invest was unanimous.”

With each of these companies, AshHill is working with the leadership team, lending expertise on critical strategic initiatives, such as the FDA approval process for bringing the HCM medication to the U.S. market.

“We have laid the groundwork in terms of securing funds and finding companies that have tremendous potential to provide an incredible return on investment between late 2012 and late 2016,” Smith said. “Our focus in 2012 is to continue to protect our investments and raise sufficient capital to maintain this level of momentum.”

For more information regarding AshHill Pharmaceutical Investments, please visit their website or contact their office directly (859) 309-6224.

About AshHill Pharmaceutical Investments, LLC
AshHill (ashhill.net) is a private limited liability company focused on creating maximum value for its members by investing in companies that primarily develop innovative products and services in various stages of research, development and approval to serve the biopharmaceutical industry.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: The Deciding Factor, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


New Healthcare Investment Firm Focuses on Unmet Medical Needs

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Karen Vance - DecidingFactor.us 
513-459-9064 public.relations[.]decidingfactor.us
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Deciding Factor, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From The Deciding Factor, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  NAKIVO, Inc.

Visit  K A C, Images and U, LLC







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today